Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration

American Journal of Physiology - Cell Physiology

Volumn 289, Issue 1 58-1, 2005, Pages

  Koh, Timothy J ^a   Bryer, Scott C ^a   Pucci, Augustina M ^a   Sisson, Thomas H ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Macrophage; Muscle inflammation; Muscle injury; Muscle repair; Urokinase type plasminogen activator

Indexed keywords

CARDIOTOXIN; MYOSIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE INHIBITOR; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; EXTENSOR DIGITORUM LONGUS MUSCLE; MACROPHAGE; MOUSE; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; WILD TYPE;

NASA DISCIPLINE MUSCULOSKELETAL; NON-NASA CENTER;

ANIMALS; DIRECT LYTIC FACTORS; HINDLIMB; MACROPHAGES; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; MUSCLE, SKELETAL; NEUTROPHILS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; REGENERATION; TOES; URINARY PLASMINOGEN ACTIVATOR;

ANIMALIA;

EID: 21144440354     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00555.2004     Document Type: Article

References (44)

1. Abraham E, Gyetko MR, Kuhn K, Arcaroli J, Strassheim D, Park JS, Shetty S, and Idell S. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J Immunol 170: 5644-5651, 2003.
2. Bonavaud S, Charrière-Bertrand C, Rey C, Leibovitch MP, Pedersen N, Frisdal E, Planus E, Blasi F, Gherardi R, and Barlovatz-Meimon G. Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion. J Cell Sci 110: 1083-1089, 1997.
3. Cantini M, Massimino ML, Bruson A, Catani C, Dalla Libera L, and Carraro U. Macrophages regulate proliferation and differentiation of satellite cells. Biochem Biophys Res Commun 202: 1688-1696, 1994.
4. Carmeliet P, Kieckens L, Schoonjans L, Ream B, van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, and Mulligan RC. Plasminogen activator inhibitor-1 gene-deficient mice. I. generation by homologous recombination and characterization. J Clin Invest 92: 2746-2755, 1993.
5. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, and Mulligan RC. Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368: 419-424, 1994.
6. Chapman HA Jr, Reilly JJ Jr, and Kobzik L. Role of plasminogen activator in degradation of extracellular matrix protein by live human alveolar macrophages. Am Rev Respir Dis 137: 412-419, 1988.
7. Chargé SBP and Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209-238, 2004.
8. Chazaud B, Bonavaud S, Plonquet A, Pouchelet M, Gherardi RK, and Barlovatz-Meimon G. Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility. Exp Cell Res 258: 237-244, 2000.
9. Chen YW, Nader GA, Baar KR, Fedele MJ, Huffman EP, and Esser KA. Response of rat muscle to acute resistance exercise defined by transcriptional and translational profiling. J Physiol 545: 27-41, 2002.
10. Farges MC, Balcerzak D, Fisher BD, Attaix D, Béchet D, Ferrara M, and Baracos VE. Increased muscle proteolysis after local trauma mainly reflects macrophage-associated lysosomal proteolysis. Am J Physiol Endocrinol Metab 282: E326-E335, 2002.
11. Festoff BW, Reddy RB, VanBecelaere M, Smirnova I, and Chao J. Activation of serpins and their cognate proteases in muscle after crush injury. J Cell Physiol 159: 11-18, 1994.
12. Fibbi G, Barletta E, Dini G, Del Rosso A, Pucci M, Cerletti M, and Del Rosso M. Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells from normal and dystrophic patients. Lab Invest 81: 27-39, 2001.
13. Fibbi G, D'Alessio S, Pucci M, Cerletti M, and Del Rosso M. Growth factor-dependent proliferation and invasion of muscle satellite cells require the cell-associated fibrinolytic system. Biol Chem 383: 127-136. 2002.
14. Gyetko MR, Chen GH, McDonald RA, Goodman R, Huffnagle GB, Wilkinson CC, Fuller JA, and Toews GB. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans: a murine transgenic model. J Clin Invest 97: 1818-1826, 1996.
15. Gyetko MR, Sud S, Kendall T, Fuller JA, Newstead MW, and Standiford TJ. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J Immunol 165: 1513-1519, 2000.
16. Hawke TJ and Carry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 91: 534-551, 2001.
17. Koh TJ and Escobedo J. Cytoskeletal disruption and small heat shock protein translocation immediately after lengthening contractions. Am J Physiol Cell Physiol 286: C713-C722, 2004.
18. Lescaudron L, Peltékian E, Fontaine-Pérus J, Paulin D, Zampieri M, Garcia L, and Parrish E. Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord 9: 72-80, 1999.
19. Lluís F, Roma J, Suelves M, Parra M, Aniorte G, Gallardo E, Ilia I, Rodríguez L, Hughes SM, Carmeliet P, Roig M, and Muñoz- Cánoves P. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo. Blood 97: 1703-1711, 2001.
20. Lyons RM, Keski-Oja J, and Moses HL. Proteolytic activation of latent transforming, growth factor-beta from fibroblast-conditioned medium. J Cell Biol 106: 1659-1665, 1988.
21. Mars WM, Zarnegar R, and Michalopoulos GK. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 143: 949-958, 1993.
22. Merly F, Lescaudron L, Rouaud T, Crossin F, and Gardahaut MF. Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 22: 724-732, 1999.
23. Minamide LS and Bamburg JR. A filter paper dye-binding assay for quantitative determination of protein without interference from reducing agents or detergents. Anal Biochem 190: 66-70, 1990.
24. Mitchell CA, McGeachie JK, and Grounds MD. Cellular differences in the regeneration of murine skeletal muscle: a quantitative histological study in SJL/J and BALB/c mice. Cell Tissue Res 269: 159-166, 1992.
25. Muñoz-Cánoves P, Miralles F, Baiget M, and Félez J. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro. Thromb Haemost 77: 526-534, 1997.
26. Murphy G, Ward R, Gavrilovic J, and Atkinson S. Physiological mechanisms for metalloproteinase activation. Matrix Suppl 1: 224-230, 1992.
27. Naldini L, Tamagnone L, Vigna E, Sachs M, Hartmann G, Birchmeier W, Daikuhara Y, Tsubouchi H, Blasi F, and Comoglio PM. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J 11: 4825-4833, 1992.
28. Pizza FX, Koh TJ, McGregor SJ, and Brooks SV. Muscle inflammatory cells after passive stretches, isometric contractions, and lengthening contractions. J Appl Physiol 92: 1873-1878, 2002.
29. Rifkin DB, Mazzieri R, Munger JS, Noguera I, and Sung J. Proteolytic control of growth factor availability. APMIS 107: 80-85, 1999.
30. Robertson TA, Maley MA, Grounds MD, and Papadimitriou JM. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp Cell Res 207: 321-331, 1993.
31. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, and Dano K. Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 2: 287-292, 1996.
32. Schultz E and McCormick KM. Skeletal muscle satellite cells. Rev Physiol Biochem Pharmacol 123: 213-257, 1994.
33. Shimizu M, Kara A, Okuno M, Matsuno H, Okada K, Ueshima S, Matsuo O, Niwa M, Akita K, Yamada Y, Yoshimi N, Uematsu T, Kojima S, Friedman SL, Moriwaki H, and Mori H. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis. Hepatology 33: 569-576, 2001.
34. Sisson TH, Hanson KE, Subbotina N, Patwardhan A, Hattori N, and Simon RH. Inducible lung-specific urokinase expression reduces fibrosis and mortality after lung injury in mice. Am J Physiol Lung Cell Mol Physiol 283: L1023-L1032, 2002.
35. Sisson TH, Hattori N, Xu Y, and Simon RH. Treatment of bleomycin-induced pulmonary fibrosis by transfer of urokinase-type plasminogen activator genes. Hum Gene Ther 10: 2315-2323, 1999.
36. 3 binding to vitronectin. Nature 383: 441-443, 1996.
37. Stepanova VV and Tkachuk VA. Urokinase as a multidomain protein and polyfunctional cell regulator. Biochemistry (Mosc) 67: 109-118, 2002.
38. Suelves M, López-Alemany R, Lluís F, Aniorte G, Serrano E, Parra M, Carmeliet P, and Muñoz-Cánoves P. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo. Blood 99: 2835-2844, 2002.
39. Tatsumi R, Anderson JE, Nevoret CJ, Halevy O, and Allen RE. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol 194: 114-128, 1998.
40. Teixeira CFP, Zamunér SR, Zuliani JP, Fernandes CM, Cruz-Hofling MA, Fernandes I, Chaves F, and Gutierrez JM. Neutrophils do not contribute to local tissue damage, but play a key role in skeletal muscle regeneration, in mice injected with Bothrops asper snake venom. Muscle Nerve 28: 449-459, 2003.
41. Waltz DA, Natkin LR, Fujita RM, Wei Y, and Chapman HA. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J Clin Invest 100: 58-67, 1997.
42. Yablonka-Reuveni Z, Seger R, and Rivera AJ. Fibroblast growth factor promotes recruitment of skeletal muscle satellite cells in young and old rats. J Histochem Cytochem 47: 23-42, 1999.
43. Zhang G, Kim H, Cai X, López-Guisa JM, Alpers CE, Liu Y, Carmeliet P, and Eddy AA. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. J Am Soc Nephrol 14: 1254-1271, 2003.
44. Zhao P, Iezzi S, Carver E, Dressman D, Gridley T, Sartorelli V, and Hoffman EP. Slug is a novel downstream target of MyoD: temporal profiling in muscle regeneration. J Biol Chem 277: 30091-30101, 2002.